EVMN Earnings Date: Mar 4, 2027 (Estimated) — Evommune, Inc.
NYSE
Updated
When is EVMN's next earnings date?
Evommune, Inc. (EVMN) is expected to report Q4 2026 earnings on Thursday, March 4, 2027 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.89 on revenue of $577,776.
How did EVMN do in its last earnings report?
In its most recent report on Aug 6, 2026 (Q2 2026), Evommune, Inc. posted EPS of -$0.89 versus the -$0.66 estimate, a miss of 32.8%. Revenue was $0 against a $1.3M estimate. The stock's 1-day post-earnings move was +5.2%.
How much does EVMN stock move after earnings?
EVMN beat EPS estimates in 1 of its last 3 reported quarters. Over the last 4 reports the stock moved an average of 5.3% (up or down) in the day after earnings.
About Evommune, Inc.
Evommune, Inc. is a United States-based clinical-stage biotechnology company dedicated to advancing novel therapeutic solutions. Their primary focus lies in addressing the underlying mechanisms of chronic inflammatory diseases. Initial clinical development efforts are concentrated on conditions such as chronic spontaneous urticaria, atopic dermatitis, and ulcerative colitis. The company's investigational portfolio features EVO756, which is being developed for the treatment of chronic spontaneous urticaria (CSU) and atopic dermatitis (AD), and EVO301, intended for atopic dermatitis (AD) and ulcerative colitis (UC). Established in 2020, Evommune operates from its headquarters in Palo Alto, California.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-06 | Q2 2026 | -0.66 | -0.89 | -32.84% | $0 | ❌ Miss | +5.23% | +5.16% | -8.30% |
| 2026-05-07 | Q1 2026 | -0.84 | -0.64 | +23.81% | $0 | ✅ Beat | +1.87% | +0.98% | -10.27% |
| 2026-03-05 | Q4 2025 | -0.75 | -1.43 | -90.67% | $0 | ❌ Miss | +5.62% | -8.41% | -2.03% |
| 2025-12-11 | Q3 2025 | — | -8.07 | — | $10,000 | — | -8.53% | -23.77% | +6.35% |
Showing last 4 quarters.